Medtronic received information via literature regarding a retrospective analysis into a hybrid technique of pulmonary valve replacement in a pediatric population.All data were collected from a single center between may 2017 and april 2019.The study population included 10 patients (predominantly female, median age 1.5 years, median weight 8.8 kg), all of whom were implanted with medtronic melody transcatheter pulmonary bioprosthetic valve (unique device identifier numbers not provided).Among all medtronic melody patients, adverse events included: sepsis leading to infective endocarditis (1 patient), wound infection (1 patient), severe pulmonary regurgitation (1 patient), and paravalvular leak (2 patients) requiring balloon angioplasty or a second valve.Based on the available information medtronic product was directly associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|